Tau Pipeline Enabling Program V (T-PEP)
Alzheimer's Association
T-PEP supports translational projects aimed at advancing potential therapies for tauopathies, including Alzheimer's disease, progressive supranuclear palsy (PSP), and frontotemporal dementia (FTD). The program focuses on development candidate selection, lead optimization, in vivo proof-of-concept, and IND-enabling studies for tau or tau-related mechanisms. Projects centered on compound or target discovery are not responsive.
Maximum award: $750,000 over 2 years
Deadlines
| UM Internal Deadline (to ADR) | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 28-May-2026 |
Application | 24-Jul-2026 | 14-Aug-2026 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.